208 related articles for article (PubMed ID: 31313075)
21. Zafirlukast protects blood-brain barrier integrity from ischemic brain injury.
Zeng C; Wang D; Chen C; Chen L; Chen B; Li L; Chen M; Xing H
Chem Biol Interact; 2020 Jan; 316():108915. PubMed ID: 31816286
[TBL] [Abstract][Full Text] [Related]
22. The neurovascular protective effect of alogliptin in murine MCAO model and brain endothelial cells.
Hao FL; Han XF; Wang XL; Zhao ZR; Guo AH; Lu XJ; Zhao XF
Biomed Pharmacother; 2019 Jan; 109():181-187. PubMed ID: 30396075
[TBL] [Abstract][Full Text] [Related]
23. Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia.
Fujimoto M; Takagi Y; Aoki T; Hayase M; Marumo T; Gomi M; Nishimura M; Kataoka H; Hashimoto N; Nozaki K
J Cereb Blood Flow Metab; 2008 Oct; 28(10):1674-85. PubMed ID: 18560439
[TBL] [Abstract][Full Text] [Related]
24. [Effect of montelukast on morphological changes in neurons after ischemic injury].
Wang XX; Zhang XY; Huang XQ; Yu SY; Zhao R; Fang SH; Lu YB; Zhang WP; Wei EQ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 May; 41(3):259-66. PubMed ID: 22723160
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of TNF-α protects in vitro brain barrier from ischaemic damage.
Abdullah Z; Rakkar K; Bath PM; Bayraktutan U
Mol Cell Neurosci; 2015 Nov; 69():65-79. PubMed ID: 26546149
[TBL] [Abstract][Full Text] [Related]
26. Montelukast protects against renal ischemia/reperfusion injury in rats.
Sener G; Sehirli O; Velioğlu-Oğünç A; Cetinel S; Gedik N; Caner M; Sakarcan A; Yeğen BC
Pharmacol Res; 2006 Jul; 54(1):65-71. PubMed ID: 16584888
[TBL] [Abstract][Full Text] [Related]
27. Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury.
Biber N; Toklu HZ; Solakoglu S; Gultomruk M; Hakan T; Berkman Z; Dulger FG
Brain Inj; 2009 Jun; 23(6):577-84. PubMed ID: 19484631
[TBL] [Abstract][Full Text] [Related]
28. Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis.
Zovko A; Yektaei-Karin E; Salamon D; Nilsson A; Wallvik J; Stenke L
Oncol Rep; 2018 Aug; 40(2):902-908. PubMed ID: 29845257
[TBL] [Abstract][Full Text] [Related]
29. 1-Trifluoromethoxyphenyl-3-(1-Propionylpiperidin-4-yl) Urea Protects the Blood-Brain Barrier Against Ischemic Injury by Upregulating Tight Junction Protein Expression, Mitigating Apoptosis and Inflammation
Yi X; Xu C; Huang P; Zhang L; Qing T; Li J; Wang C; Zeng T; Lu J; Han Z
Front Pharmacol; 2020; 11():1197. PubMed ID: 32848796
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.
Feng S; Cen J; Huang Y; Shen H; Yao L; Wang Y; Chen Z
PLoS One; 2011; 6(8):e20599. PubMed ID: 21857898
[TBL] [Abstract][Full Text] [Related]
31. Improvement of hepatic fibrosis by leukotriene inhibition in cholestatic rats.
El-Swefy S; Hassanen SI
Ann Hepatol; 2009; 8(1):41-9. PubMed ID: 19221533
[TBL] [Abstract][Full Text] [Related]
32. Effect of Montelukast on Bronchopulmonary Dysplasia (BPD) and Related Mechanisms.
Chen X; Zhang X; Pan J
Med Sci Monit; 2019 Mar; 25():1886-1893. PubMed ID: 30862773
[TBL] [Abstract][Full Text] [Related]
33. Cysteinyl leukotriene receptor 1 promotes 5-fluorouracil resistance and resistance-derived stemness in colon cancer cells.
Satapathy SR; Sjölander A
Cancer Lett; 2020 Sep; 488():50-62. PubMed ID: 32474153
[TBL] [Abstract][Full Text] [Related]
34. Effect of magnolol on cerebral injury and blood brain barrier dysfunction induced by ischemia-reperfusion in vivo and in vitro.
Liu X; Chen X; Zhu Y; Wang K; Wang Y
Metab Brain Dis; 2017 Aug; 32(4):1109-1118. PubMed ID: 28378105
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat.
Yang Y; Estrada EY; Thompson JF; Liu W; Rosenberg GA
J Cereb Blood Flow Metab; 2007 Apr; 27(4):697-709. PubMed ID: 16850029
[TBL] [Abstract][Full Text] [Related]
36. At low doses ethanol maintains blood-brain barrier (BBB) integrity after hypoxia and reoxygenation: a brain slice study.
Peng C; Li WA; Fu P; Chakraborty T; Hussain M; Guthikonda M; Rafols JA; Ding Y
Neurol Res; 2013 Oct; 35(8):790-7. PubMed ID: 23582053
[TBL] [Abstract][Full Text] [Related]
37. TIMP-1 Protects Tight Junctions of Brain Endothelial Cells From MMP-Mediated Degradation.
Ahmadighadykolaei H; Lambert JA; Raeeszadeh-Sarmazdeh M
Pharm Res; 2023 Sep; 40(9):2121-2131. PubMed ID: 37700105
[TBL] [Abstract][Full Text] [Related]
38. Rosavin protects the blood-brain barrier against ischemia/reperfusion-induced cerebral injury by regulating MAPK-mediated MMPs pathway.
Zou H; Li L; Yang Z; Tang L; Wang C
Clin Exp Pharmacol Physiol; 2023 Aug; 50(8):664-676. PubMed ID: 37254848
[TBL] [Abstract][Full Text] [Related]
39. The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies.
Marschallinger J; Altendorfer B; Rockenstein E; Holztrattner M; Garnweidner-Raith J; Pillichshammer N; Leister I; Hutter-Paier B; Strempfl K; Unger MS; Chishty M; Felder T; Johnson M; Attems J; Masliah E; Aigner L
Neurotherapeutics; 2020 Jul; 17(3):1061-1074. PubMed ID: 32072462
[TBL] [Abstract][Full Text] [Related]
40. Melatonin protects blood-brain barrier integrity and permeability by inhibiting matrix metalloproteinase-9 via the NOTCH3/NF-κB pathway.
Qin W; Li J; Zhu R; Gao S; Fan J; Xia M; Zhao RC; Zhang J
Aging (Albany NY); 2019 Dec; 11(23):11391-11415. PubMed ID: 31811815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
